4 Financial Instruments
4.1 Accounting classification
The following table shows the carrying amounts of financial assets and financial liabilities.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or, in its absence, the most advantageous market to which FMO has access at that date.
June 30, 2025 |
||||||
FVPL |
Fair value hedging instruments |
FVOCI-equity instruments |
Amortized cost |
Financial liabilities used as hedged items |
Total |
|
Financial assets |
||||||
Cash balances with Banks |
- |
- |
- |
185,314 |
- |
185,314 |
Current accounts with state funds and other programs |
- |
- |
- |
1,172 |
- |
1,172 |
Short-term deposits |
65,963 |
- |
- |
1,614,521 |
- |
1,680,484 |
Other receivables |
- |
- |
- |
20,682 |
- |
20,682 |
Interest-bearing securities |
132,435 |
- |
- |
427,676 |
- |
560,111 |
Derivative financial instruments |
147,215 |
60,565 |
- |
- |
- |
207,780 |
Loans to the private sector |
641,478 |
- |
- |
4,612,867 |
- |
5,254,345 |
Accrued assets |
- |
- |
- |
988 |
- |
988 |
Equity investments |
2,056,198 |
- |
184,336 |
- |
- |
2,240,534 |
Total Financial assets |
3,043,289 |
60,565 |
184,336 |
6,863,220 |
- |
10,151,410 |
Financial liabilities |
||||||
Short-term credits |
- |
- |
- |
267,599 |
- |
267,599 |
Current accounts with state funds and other programs |
- |
- |
- |
10,547 |
- |
10,547 |
Derivative financial instruments |
172,234 |
68,965 |
- |
- |
- |
241,199 |
Other financial liabilities |
100,457 |
- |
- |
- |
- |
100,457 |
Debentures and notes |
- |
- |
- |
875,927 |
5,259,776 |
6,135,703 |
Accrued liabilities |
- |
- |
- |
86,963 |
- |
86,963 |
Other liabilities |
- |
- |
- |
23,948 |
- |
23,948 |
Total Financial liabilities |
272,691 |
68,965 |
- |
1,264,984 |
5,259,776 |
6,866,416 |
During the current period FMO acquired new interest bearing securities. Interest rate swaps are entered into to manage the risk associated with the securities and these swaps are measured at fair value through profit and loss. Therefore, to eliminate a possible accounting mismatch, the interest bearing securities are designated at fair value through profit and loss. The maximum credit exposure of the securities is €131 million and the cumulative change in fair value for the period is a gain of €1 million. The notional value of the swaps is €130 million, and the cumulative change in fair value for the period is a loss of €2 million. The movements in fair value are attributable nearly completely to market risk.
December 31, 2024 |
||||||
Fair Value P&L |
Fair value hedging instruments |
FVOCI-equity instruments |
Amortized cost |
Financial liabilities used as hedged items |
Total |
|
Financial assets |
||||||
Cash balances with Banks |
- |
- |
- |
43,087 |
- |
43,087 |
Current accounts with state funds and other programs |
- |
- |
- |
1,336 |
- |
1,336 |
Short-term deposits |
369,481 |
- |
- |
1,111,886 |
- |
1,481,367 |
Other receivables |
- |
- |
- |
18,393 |
- |
18,393 |
Interest-bearing securities |
107,596 |
- |
- |
481,798 |
- |
589,394 |
Derivative financial instruments |
98,600 |
27,739 |
- |
- |
- |
126,339 |
Loans to the private sector |
652,061 |
- |
- |
5,190,518 |
- |
5,842,579 |
Equity investments |
2,355,626 |
- |
201,287 |
- |
- |
2,556,913 |
Total Financial assets |
3,583,364 |
27,739 |
201,287 |
6,846,946 |
- |
10,659,408 |
Financial liabilities |
||||||
Short-term credits |
- |
- |
- |
216,912 |
- |
216,912 |
Current accounts with state funds and other programs |
- |
- |
- |
93 |
- |
93 |
Derivative financial instruments |
339,658 |
131,728 |
- |
- |
- |
471,386 |
Other financial liabilities |
121,715 |
- |
- |
- |
- |
121,715 |
Debentures and notes |
- |
- |
- |
863,404 |
5,472,577 |
6,335,981 |
Accrued liabilities |
- |
- |
- |
38,683 |
- |
38,683 |
Other liabilities |
- |
- |
- |
18,923 |
- |
18,923 |
Total Financial liabilities |
461,373 |
131,728 |
- |
1,137,953 |
5,472,577 |
7,203,693 |
In this condensed consolidated interim financial statements, immaterial presentation updates have been made to aggregate 'Wage tax assets' and 'Wage tax liabilities', which were presented separately in the 31 December 2024 consolidated annual financial statements, with 'Other receivables' and 'Other liabilities', respectively.
4.2 Short-term deposits
June 30, 2025 |
December 31, 2024 |
|
Collateral delivered (related to derivative financial instruments) |
189,914 |
381,245 |
Cash held at central bank |
1,402,291 |
702,745 |
Mandatory reserve deposit with Dutch central bank |
4,296 |
8,211 |
Collateral delivered to European Central Bank |
2,946 |
2,946 |
Other short-term deposits |
15,074 |
16,739 |
Short term deposits measured at AC |
1,614,521 |
1,111,886 |
Commercial paper |
- |
240,726 |
Money market funds |
65,963 |
128,755 |
Short term deposits measured at FVPL |
65,963 |
369,481 |
Balance at December 31 |
1,680,484 |
1,481,367 |
Mandatory reserve represents the average daily target set by regulator and is not available for user in FMO’s day-to-day operations. Furthermore, FMO's investments in commercial paper matured during 2025.
4.3 Derivatives
FMO uses various derivatives to hedge its assets and liabilities against interest rate risk and market risk. During the first half of 2025, the derivatives position has decreased and is related to maturing or termination of interest rate swaps and cross - currency interest swaps (see tables below). Changes in the curves and FX were the main drivers for the changes in fair value.
The following table summarizes the notional amounts and the fair values of derivatives. Some derivatives are held to reduce interest rate risks and currency risks but do not meet the specified criteria to apply hedge accounting for the reporting period. The table also includes derivatives related to the asset portfolio.
2025 |
||||||
Carrying amount |
||||||
Notional amount |
Assets |
Liabilities |
Change in fair value used for calculating hedge ineffectiveness |
Ineffectiveness recorded in profit or loss |
Line item in P&L that includes hedge ineffectiveness |
|
Derivatives hedge accounting instruments: |
||||||
Interest rate swaps |
5,261,258 |
60,565 |
68,965 |
76,522 |
-3,814 |
Results from financial transactions |
Derivatives other than hedge accounting instruments: |
||||||
Currency swaps |
410,968 |
466 |
4,363 |
|||
Interest rate swaps |
2,817,531 |
20,104 |
9,899 |
|||
Cross-currency interest rate swaps |
3,331,428 |
126,645 |
148,390 |
|||
Subtotal |
6,559,927 |
147,215 |
162,652 |
|||
Embedded derivatives related to asset portfolio |
- |
9,582 |
||||
Total derivative assets /(liabilities) other than hedge accounting instruments |
6,559,927 |
147,215 |
172,234 |
|||
Balance at June 30 |
11,821,185 |
207,780 |
241,199 |
2024 |
||||||
Carrying amount |
||||||
Notional amount |
Assets |
Liabilities |
Change in fair value used for calculating hedge ineffectiveness |
Ineffectiveness recorded in profit or loss |
Line item in P&L that includes hedge ineffectiveness |
|
Derivatives hedge accounting instruments: |
||||||
Interest rate swaps |
5,541,648 |
27,739 |
131,728 |
48,680 |
7,254 |
Results from financial transactions |
Derivatives other than hedge accounting instruments: |
||||||
Currency swaps |
319,791 |
2,687 |
389 |
|||
Interest rate swaps |
3,055,885 |
41,008 |
5,537 |
|||
Cross-currency interest rate swaps |
3,349,386 |
54,905 |
321,490 |
|||
Subtotal |
6,725,062 |
98,600 |
327,416 |
|||
Embedded derivatives related to asset portfolio |
- |
12,242 |
||||
Total derivative assets /(liabilities) other than hedge accounting instruments |
6,725,062 |
98,600 |
339,658 |
|||
Balance at December 31 |
12,266,710 |
126,339 |
471,386 |
The amounts relating to items designated as hedged items were as follows:
2025 |
|||||
Carrying amount of the hedged item |
Accumulated amount of fair value hedge adjustments on the hedged item included in the carrying amount of the hedged item |
||||
Balance sheet line item |
Liabilities |
Assets |
Liabilities |
Change in fair value used for calculating hedge ineffectiveness |
Accumulated amount remaining in the balance sheet for any hedged items that have ceased to be adjusted for hedging gains and losses |
Debentures and notes |
5,259,776 |
- |
- |
-80,336 |
- |
Balance at June 30 |
5,259,776 |
- |
- |
-80,336 |
- |
2024 |
|||||
Carrying amount of the hedged item |
Accumulated amount of fair value hedge adjustments on the hedged item included in the carrying amount of the hedged item |
||||
Balance sheet line item |
Liabilities |
Assets |
Liabilities |
Change in fair value used for calculating hedge ineffectiveness |
Accumulated amount remaining in the balance sheet for any hedged items that have ceased to be adjusted for hedging gains and losses |
Debentures and notes |
5,472,577 |
- |
- |
-41,426 |
- |
Balance at December 31 |
5,472,577 |
- |
- |
-41,426 |
- |
4.4 Equity Investments
The overall change in fair value as per June 2025 is mainly driven by FX exchange results. Unrealized results from capital movement for FVPL positions is €13.9 million, please also refer to note 11.
Equity measured at FVOCI |
Equity measured at FVPL |
Total |
|
Net balance at January 1, 2025 |
201,287 |
2,355,626 |
2,556,913 |
Purchases and contributions |
119 |
125,738 |
125,857 |
Conversion of loans to equity |
- |
3,311 |
3,311 |
Return of Capital (including sales) |
- |
-216,869 |
-216,869 |
Changes in fair value |
-17,070 |
-211,608 |
-228,678 |
Total balance at June 30, 2025 |
184,336 |
2,056,198 |
2,240,534 |
Equity measured at FVOCI |
Equity measured at FVPL |
Total |
|
Balance at January 1, 2024 |
167,074 |
2,193,771 |
2,360,845 |
Purchases and contributions |
120 |
329,824 |
329,944 |
Conversion of loans to equity |
- |
289 |
289 |
Transfer associate/FVPL |
- |
- |
- |
Return of capital (including sales) |
- |
-329,927 |
-329,927 |
Changes in fair value |
34,093 |
161,669 |
195,762 |
Balance at December 31, 2024 |
201,287 |
2,355,626 |
2,556,913 |
4.5 Investments in associates & Joint Ventures
June 30, 2025 |
December 31, 2024 |
|
Net balance |
372,073 |
308,179 |
Purchases and contributions |
15,367 |
7,338 |
Conversion from loans to equity |
4,386 |
7,887 |
Conversion Associates/FVPL |
- |
- |
Return of capital (including sales) |
-2,769 |
- |
Share in net results |
34,152 |
39,483 |
Exchange rate differences |
-57,538 |
9,186 |
Total |
365,671 |
372,073 |
4.6 Other Financial Liabilities
June 30, 2025 |
December 31, 2024 |
|
Net Balance |
121,715 |
74,003 |
Purchases and contributions |
2,417 |
7,280 |
Return of Capital (including sales) |
-102 |
0 |
Changes in fair value through profit & loss |
-13,510 |
-14,233 |
Other changes |
-10,063 |
-200 |
Other additions |
- |
54,865 |
Total |
100,457 |
121,715 |
The financial liabilities contained in this note relate to amounts payable to the Dutch government as a part of their participation in the program. Other changes relate to the recognition of liabilities for FMO's obligations to the public fund programs managed on behalf of the Dutch State. Other additions line item relates to the consolidation in 2024 of the Land Use Facility of the Dutch Fund for Climate Development (DFCD) and represents the amounts payable to the Dutch government as a result of their participation in the program.
4.7 Fair values
Fair value hierarchy
All financial instruments for which fair value is recognized or disclosed are categorized within the fair value hierarchy, based on lowest level input that is significant to the fair value measurement as a whole, as follows:
Level 1 – Quoted (unadjusted) market prices in active markets for identical assets or liabilities.
Level 2 – Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.
Level 3 – Valuation technique for which the lowest level input that is significant to the fair value measurement is unobservable.
Valuation processes
For recurring and non-recurring fair value measurements categorized within Level 3 of the fair value hierarchy, FMO uses the valuation processes to decide its valuation policies and procedures and analyze changes in fair value measurement from period to period.
FMO’s fair value methodology and governance over applied methods includes a number of controls and other procedures to ensure appropriate safeguards are in place to ensure quality and adequacy. The responsibility of ongoing measurement resides with the relevant departments. Once submitted, fair value estimates are also reviewed and challenged by the Financial Risk Committee (FRC). The FRC approves the fair values measured including the valuation techniques and other significant input parameters used. The appropriateness of the valuation techniques applicable to the underlying instruments is assessed as part of the valuation process and any potential changes between levels in the fair value hierarchy are considered.
Valuation techniques
When available, the fair value of an instrument is measured by using the quoted price in an active market for that instrument (level 1). A market is regarded as active if transactions of the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
If there is no quoted price in an active market, valuation techniques are used that maximize the use of relevant observable inputs and minimize the use of unobservable inputs. Valuation techniques include:
-
Recent broker/ price quotations
-
Discounted cash flow models
-
Option-pricing models
The techniques incorporate current market and contractual prices, time to expiry, yield curves and volatility of the underlying instrument. Inputs used in pricing models are market observable (level 2) or are not market observable (level 3). A substantial part of fair value (level 3) is based on net asset values.
Investments are measured at fair value when a quoted market price in an active market is available or when fair value can be estimated reliably by using a valuation technique. The main part of the fair value measurement related to investments (level 3) is based on net asset values of investment funds as reported by the fund manager and are based on advanced valuation methods and practices. When available, these fund managers value the underlying investments based on quoted prices, if not available multiples are applied as input for the valuation.
The following table presents the carrying value and estimated fair value of FMO’s non fair value financial assets and liabilities.
The carrying values in the financial asset and liability categories are valued at amortized cost except for the funding in connection with hedge accounting.
Financial assets-liabilities not measured at fair value |
||||
June 30, 2025 |
December 31, 2024 |
|||
Carrying amount |
Fair value |
Carrying amount |
Fair value |
|
Financial assets not measured at fair value |
||||
Short term deposits at AC |
1,614,521 |
1,614,521 |
1,111,886 |
1,111,886 |
Cash balances with Banks |
185,314 |
185,314 |
43,087 |
43,087 |
Interest-bearing securities |
427,676 |
421,182 |
481,798 |
470,770 |
Loans to the private sector at AC |
4,612,867 |
4,427,047 |
5,190,518 |
5,027,228 |
Current accounts with state funds and other programs |
1,172 |
1,172 |
1,336 |
1,336 |
Other receivables |
20,682 |
20,682 |
18,321 |
18,321 |
Total financial assets not measured at fair value |
6,862,232 |
6,669,918 |
6,846,946 |
6,672,628 |
Financial liabilities not measured at fair value |
||||
Short-term credits |
267,599 |
267,599 |
216,912 |
216,912 |
Debentures and notes |
6,135,703 |
6,206,370 |
6,335,981 |
6,431,967 |
Current accounts with state funds and other programs |
10,547 |
10,547 |
93 |
93 |
Accrued liabilities |
86,963 |
86,963 |
38,683 |
38,683 |
Other liabilities |
23,948 |
23,948 |
18,861 |
18,861 |
Total financial liabilities not measured at fair value |
6,524,760 |
6,595,427 |
6,610,530 |
6,706,516 |
The valuation technique we use for the fair value determination of loans to the private sector and non-hedged funding is based on the discounted cash-flow method. The discount rate we apply is calculated per loan by transforming market-based data to match the characteristics of the assessed loan.
The following table gives an overview of the financial instruments valued at fair value using a fair value hierarchy that reflects the significance of the inputs used in making the measurements.
June 30, 2025 |
Level 1 |
Level 2 |
Level 3 |
Total |
Financial assets mandatorily at FVPL |
||||
Short-term deposits |
65,963 |
- |
- |
65,963 |
Derivative financial instruments |
- |
207,780 |
- |
207,780 |
Loans to the private sector |
87,255 |
- |
554,223 |
641,478 |
Equity investments |
33,717 |
- |
2,022,481 |
2,056,198 |
Financial assets designated at FVPL |
||||
Interest bearing securities |
132,435 |
- |
- |
132,435 |
Financial assets at FVOCI |
||||
Equity investments |
- |
- |
184,336 |
184,336 |
Total financial assets at fair value |
319,370 |
207,780 |
2,761,040 |
3,288,190 |
Financial liabilities mandatorily at FVPL |
||||
Derivative financial instruments |
- |
231,617 |
9,582 |
241,199 |
Financial liabilities designated at FVPL |
||||
Other financial liabilities |
- |
- |
100,457 |
100,457 |
Total financial liabilities at fair value |
- |
231,617 |
110,039 |
341,656 |
December 31, 2024 |
Level 1 |
Level 2 |
Level 3 |
Total |
Financial assets mandatorily at FVPL |
||||
Short-term deposits |
128,755 |
240,726 |
- |
369,481 |
Derivative financial instruments |
- |
126,339 |
- |
126,339 |
Loans to the private sector |
99,857 |
- |
552,204 |
652,061 |
Equity investments |
23,881 |
- |
2,331,745 |
2,355,626 |
Financial assets designated at FVPL |
||||
Interest-bearing securities at FVTPL |
107,596 |
- |
- |
107,596 |
Financial assets at FVOCI |
||||
Equity investments |
- |
- |
201,287 |
201,287 |
Total financial assets at fair value |
360,089 |
367,065 |
3,085,236 |
3,812,390 |
Financial liabilities mandatorily at FVPL |
||||
Derivative financial instruments |
- |
459,144 |
12,242 |
471,386 |
Financial liabilities designated at FVPL |
||||
Other financial liabilities |
- |
- |
121,715 |
121,715 |
Total financial liabilities at fair value |
- |
459,144 |
133,957 |
593,101 |
Movements in financial instruments measured at fair value based on level 3 |
Derivative financial instruments |
Loans to the private sector |
Equity investments |
Total financial assets |
Balance at Januari 1, 2024 |
- |
500,458 |
2,327,880 |
2,828,338 |
Total gains or losses |
||||
-In profit and loss (changes In fair value) |
- |
2,863 |
51,875 |
54,738 |
-In other comprehensive income (changes in fair value) |
- |
- |
34,093 |
34,093 |
Purchases /disbursements |
- |
56,064 |
329,945 |
386,009 |
Sales/repayments |
- |
-55,088 |
-326,091 |
-381,179 |
Interest capitalization |
- |
2,252 |
- |
2,252 |
Write-offs |
- |
-1,603 |
- |
-1,603 |
Accrued income |
- |
4,397 |
- |
4,397 |
Exchange rate differences |
- |
28,217 |
115,041 |
143,258 |
Derecognition and/or restructuring FVPL versus AC |
- |
11,203 |
- |
11,203 |
Conversion from loans to equity |
- |
-289 |
289 |
- |
Conversion associate/FVPL |
- |
- |
- |
- |
Transfers into level 3 |
- |
3,730 |
- |
3,730 |
Transfers out of level 3 |
- |
- |
- |
- |
Other changes |
- |
- |
- |
- |
Balance at December 31, 2024 |
- |
552,204 |
2,533,032 |
3,085,236 |
Total gains or losses |
||||
-In profit and loss (changes In fair value) |
- |
4,399 |
-7,546 |
-3,147 |
-In other comprehensive income (changes in fair value) |
- |
- |
-17,070 |
-17,070 |
Purchases /disbursements |
- |
92,493 |
125,855 |
218,348 |
Sales/repayments |
- |
-14,244 |
-216,869 |
-231,113 |
Interest Capitalization |
- |
478 |
- |
478 |
Write-offs |
- |
-10,873 |
- |
-10,873 |
Accrued income |
- |
-5,889 |
- |
-5,889 |
Reclassification Loans versus Equity |
- |
-1,202 |
3,311 |
2,109 |
Exchange rate differences |
- |
-63,143 |
-213,896 |
-277,039 |
Balance at June 30, 2025 |
- |
554,223 |
2,206,817 |
2,761,040 |
Valuation techniques and unobservable inputs used measuring fair value of loans to the private sector
Type of debt investment |
Fair value at June 30, 2025 |
Valuation technique |
Range (weighted average) of significant unobservable inputs |
Fair value measurement sensitivity to unobservable inputs |
Loans |
67,023 |
Discounted cash flow model |
Based on client spread change for fixed rate loans at FVTPL |
A decrease/increase of the used spreads with 1% will result is a higher/lower fair value of approx €2.0 million |
161,378 |
ECL measurement |
Based on client rating for floating rate loans at FVTPL |
An improvement / deterioration of the Client Rating with 1 notch wil result approx 0.4% increase/decrease |
|
35,328 |
Credit impairment |
n/a |
n/a |
|
Debt Funds |
290,494 |
Net Asset Value |
n/a |
n/a |
Total |
554,223 |
Valuation techniques and unobservable inputs used measuring fair value of equity investments
Type of equity investment |
Fair value at June 30, 2025 |
Valuation technique |
Range (weighted average) of significant unobservable inputs |
Fair value measurement sensitivity to unobservable inputs of 10% |
Private equity fund investments |
1,247,390 |
Net Asset Value |
Discounts applied ranging from 10 to 100% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 4.3 million. |
Private equity direct investments |
47,674 |
Recent transactions |
Discounts applied ranging from 50 to 75% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 0.4 million. |
405,994 |
Book multiples |
Discounts applied ranging from 10 to 90% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 2.2 million. |
|
218,055 |
Earning Multiples |
Discounts applied ranging from 10 to 40% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 2.0 million. |
|
107,090 |
Discounted Cash Flow (DCF) |
Discounts applied ranging from 20 to 50% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 0.2 million. |
|
75,324 |
Put option |
Discounts applied ranging from 10 to 29% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 0.9 million. |
|
46,787 |
Firm offers |
Discounts applied 10% |
Changes in the discounts applied would result in a lower/ higher fair value in valuation of EUR 0.5 million. |
|
58,503 |
Cost |
N/A |
N/A |
|
Total |
2,206,817 |